Notice of General Meeting

RNS Number : 8781N
e-Therapeutics plc
25 February 2009
 



Press Release 

25 February 2009



e-Therapeutics plc


('e-therapeutics' or the 'Company')


Notice of General Meeting



Further to the announcement made earlier today, the Company confirms that a circular has now been dispatched to shareholders to convene a general meeting ('GM') of the Company at 10.30 am on 16 March 2009 at the Company's registered office, Holland Park, Holland Drive, Newcastle upon Tyne, NE2 4LZ.  


A copy of the circular is available from the Company's website www.etherapeutics.co.uk.


At the General Meeting the following resolutions will be proposed:


  • an ordinary resolution to increase the authorised share capital of the Company from £83,766.47 to £100,218.15 by the creation of an additional 16,451,684 new Ordinary Shares;

  • an ordinary resolution to authorise directors to allot relevant securities pursuant to section 80 of the Companies Act 1985 up to aggregate maximum nominal amount of £44,508.05; and

  • a special resolution to disapply the pre-emption provision contained in section 89(1) of the Companies Act 1985 in respect of the allotment of equity securities up to an aggregate nominal amount of £21,824.01 in connection with the authority referred to in (2) above.


For further information:



John Cordiner, e-Therapeutics plc

+44 (0) 191 233 1317


Katy Mitchell/David Youngman WH Ireland Limited



+44 (0) 113 394 6628

 

  Media enquiries:

Abchurch Communications

www.abchurch-group.com

+44 (0) 207 398 7700

Heather Salmond

heather.salmond@abchurch-group.com

+44 (0) 207 398 7704

Stephanie Cuthbert

stephanie.cuthbert@abchurch-group.com

+44 (0) 207 398 7718

Simone Alves

simone.alves@abchurch-group.com

+44 (0) 207 398 7728






This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOESESFLISUSEIE
UK 100

Latest directors dealings